Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome
Condition: Abdominal Obesity Metabolic Syndrome
Interventions: Drug: ALS-L1023; Drug: placebo
Sponsor: Hanmi Pharmaceutical Company Limited
Terminated - verified October 2016
Interventions: Drug: ALS-L1023; Drug: placebo
Sponsor: Hanmi Pharmaceutical Company Limited
Terminated - verified October 2016